 |
The Journal of Neuroscience, March 24, 2004, 24(12):2963-2973; doi:10.1523/JNEUROSCI.0155-04.2004
Previous Article | Next Article 
Cellular/Molecular
Nuclear Factor- B Modulates the p53 Response in Neurons Exposed to DNA Damage
Hossein Aleyasin,
Sean P. Cregan,
Grace Iyirhiaro,
Michael J. O'Hare,
Steve M. Callaghan,
Ruth S. Slack, and
David S. Park
Ottawa Health Research Institute, Neurosciences, East Division, Ottawa, Ontario, Canada K1H 8M5
Previous studies have shown that DNA damage-evoked death of primary cortical neurons occurs in a p53 and cyclin-dependent kinase-dependent (CDK) manner. The manner by which these signals modulate death is unclear. Nuclear factor- B (NF- B) is a group of transcription factors that potentially interact with these pathways. Presently, we show that NF- B is activated shortly after induction of DNA damage in a manner independent of the classic I B kinase (IKK) activation pathway, CDKs, ATM, and p53. Acute inhibition of NF- B via expression of a stable I B mutant, downregulation of the p65 NF- B subunit by RNA interference (RNAi), or pharmacological NF- B inhibitors significantly protected against DNA damage-induced neuronal death. NF- B inhibition also reduced p53 transcripts and p53 activity as measured by the p53-inducible messages, Puma and Noxa, implicating the p53 tumor suppressor in the mechanism of NF- B-mediated neuronal death. Importantly, p53 expression still induces death in the presence of NF- B inhibition, indicating that p53 acts downstream of NF- B. Interestingly, neurons cultured from p65 or p50 NF- B-deficient mice were not resistant to death and did not show diminished p53 activity, suggesting compensatory processes attributable to germline deficiencies, which allow p53 activation still to occur. In contrast to acute NF- B inhibition, prolonged NF- B inhibition caused neuronal death in the absence of DNA damage. These results uniquely define a signaling paradigm by which NF- B serves both an acute p53-dependent pro-apoptotic function in the presence of DNA damage and an anti-apoptotic function in untreated normal neurons.
Key words: embryonic cortical neurons; NF- B; camptothecin; p53; DNA damage; I B; apoptosis
Received Sep 9, 2003;
revised February 7, 2004;
accepted February 7, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
T. Suzuki, C. Yamashita, R. L. Zemans, N. Briones, A. Van Linden, and G. P. Downey
Leukocyte Elastase Induces Lung Epithelial Apoptosis via a PAR-1-, NF-{kappa}B-, and p53-Dependent Pathway
Am. J. Respir. Cell Mol. Biol.,
December 1, 2009;
41(6):
742 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Venderova, G. Kabbach, E. Abdel-Messih, Y. Zhang, R. J. Parks, Y. Imai, S. Gehrke, J. Ngsee, M. J. LaVoie, R. S. Slack, et al.
Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
Hum. Mol. Genet.,
November 15, 2009;
18(22):
4390 - 4404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jiang and Z. Dong
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
J. Pharmacol. Exp. Ther.,
November 1, 2008;
327(2):
300 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. R. Gonzalez, Y. Zhang, D. Behzadpoor, S. Cregan, S. Bamforth, R. S. Slack, and D. S. Park
CITED2 Signals through Peroxisome Proliferator-Activated Receptor-{gamma} to Regulate Death of Cortical Neurons after DNA Damage
J. Neurosci.,
May 21, 2008;
28(21):
5559 - 5569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Haque, K. J. Thomas, C. D'Souza, S. Callaghan, T. Kitada, R. S. Slack, P. Fraser, M. R. Cookson, A. Tandon, and D. S. Park
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
PNAS,
February 5, 2008;
105(5):
1716 - 1721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Inta, S. Paxian, I. Maegele, W. Zhang, M. Pizzi, P. Spano, I. Sarnico, S. Muhammad, O. Herrmann, D. Inta, et al.
Bim and Noxa Are Candidates to Mediate the Deleterious Effect of the NF-{kappa}B Subunit RelA in Cerebral Ischemia
J. Neurosci.,
December 13, 2006;
26(50):
12896 - 12903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, D. Qu, E. J. Morris, M. J. O'Hare, S. M. Callaghan, R. S. Slack, H. M. Geller, and D. S. Park
The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin.
J. Neurosci.,
August 23, 2006;
26(34):
8819 - 8828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kitaoka, Y. Kitaoka, J. M. K. Kwong, F. N. Ross-Cisneros, J. Wang, R. K. Tsai, A. A. Sadun, and T. T. Lam
TNF-{alpha}-Induced Optic Nerve Degeneration and Nuclear Factor-{kappa}B p65.
Invest. Ophthalmol. Vis. Sci.,
April 1, 2006;
47(4):
1448 - 1457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tabakin-Fix, I. Azran, Y. Schavinky-Khrapunsky, O. Levy, and M. Aboud
Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications
Carcinogenesis,
April 1, 2006;
27(4):
673 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lang, B. A. Schulte, D. Zhou, N. Smythe, S. S. Spicer, and R. A. Schmiedt
Nuclear factor kappaB deficiency is associated with auditory nerve degeneration and increased noise-induced hearing loss.
J. Neurosci.,
March 29, 2006;
26(13):
3541 - 3550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yang, M. Fraser, U. M. Moll, A. Basak, and B. K. Tsang
Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway.
Cancer Res.,
March 15, 2006;
66(6):
3126 - 3136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Uo, Y. Kinoshita, and R. S. Morrison
Neurons Exclusively Express N-Bak, a BH3 Domain-only Bak Isoform That Promotes Neuronal Apoptosis
J. Biol. Chem.,
March 11, 2005;
280(10):
9065 - 9073.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|